Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise van Hout

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|July 27, 2020
Microevolution of acquired colistin resistance in Enterobacteriaceae from ICU patients receiving selective decontamination of the digestive tractAxel B Janssen, Denise van Hout, Marc J M Bonten, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2026
From rigid to rapid: rethinking clinical trial processes for emergency-ready clinical trialsDenise van Hout, Cristina Prat-Aymerich, Karen van Hulst, et al.
Plos One|February 7, 2022
The experience of European hospital-based health care workers on following infection prevention and control procedures and their wellbeing during the first wave of the COVID-19 pandemicDenise van Hout, Paul Hutchinson, Marta Wanat, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 7, 2019
The added value of the selective SuperPolymyxin™ medium in detecting rectal carriage of Gram-negative bacteria with acquired colistin resistance in intensive care unit patients receiving selective digestive decontaminationDenise van Hout, Axel B Janssen, Rob J Rentenaar, et al.
Plos One|January 15, 2020
Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014 - 2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene contentDenise van Hout, Tess D Verschuuren, Patricia C J Bruijning-Verhagen, et al.
NEJM Evidence|June 25, 2024
Influenza Infection and Acute Myocardial InfarctionAnnemarijn R de Boer, Annelies Riezebos-Brilman, Denise van Hout, et al.
BMJ Open|September 9, 2019
Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysisDenise van Hout, Nienke L Plantinga, Patricia C Bruijning-Verhagen, et al.
Contemporary Clinical Trials Communications|April 9, 2026
Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseasesAmos J de Jong, Denise van Hout, Janneke D M Verberk, et al.
JAMA Network Open|July 2, 2025
Hurdles for the Delivery of Multinational Randomized Clinical TrialsDenise van Hout, Paul Mouncey, David Harrison, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|July 27, 2020
Microevolution of acquired colistin resistance in Enterobacteriaceae from ICU patients receiving selective decontamination of the digestive tractAxel B Janssen, Denise van Hout, Marc J M Bonten, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2026
From rigid to rapid: rethinking clinical trial processes for emergency-ready clinical trialsDenise van Hout, Cristina Prat-Aymerich, Karen van Hulst, et al.
Plos One|February 7, 2022
The experience of European hospital-based health care workers on following infection prevention and control procedures and their wellbeing during the first wave of the COVID-19 pandemicDenise van Hout, Paul Hutchinson, Marta Wanat, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 7, 2019
The added value of the selective SuperPolymyxin™ medium in detecting rectal carriage of Gram-negative bacteria with acquired colistin resistance in intensive care unit patients receiving selective digestive decontaminationDenise van Hout, Axel B Janssen, Rob J Rentenaar, et al.
Plos One|January 15, 2020
Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014 - 2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene contentDenise van Hout, Tess D Verschuuren, Patricia C J Bruijning-Verhagen, et al.
NEJM Evidence|June 25, 2024
Influenza Infection and Acute Myocardial InfarctionAnnemarijn R de Boer, Annelies Riezebos-Brilman, Denise van Hout, et al.
BMJ Open|September 9, 2019
Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysisDenise van Hout, Nienke L Plantinga, Patricia C Bruijning-Verhagen, et al.
Contemporary Clinical Trials Communications|April 9, 2026
Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseasesAmos J de Jong, Denise van Hout, Janneke D M Verberk, et al.
JAMA Network Open|July 2, 2025
Hurdles for the Delivery of Multinational Randomized Clinical TrialsDenise van Hout, Paul Mouncey, David Harrison, et al.
Pageof 1